Streetbeat News

Earnings

GOOG

GOOGL

Alphabet shares are trading higher after the company reported better-than-expected Q3 earnings.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:47 am

LLY

Eli Lilly's Q3 2024 earnings and sales missed analyst estimates, with EPS at $1.18 versus the expected $1.45, and sales at $11.44 billion versus the expected $12.10 billion. Despite the miss, both EPS and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:46 am

XPO

XPO reported Q3 2024 earnings per share of $1.02, surpassing the analyst estimate of $0.91. The company's sales were $2.053 billion, exceeding the expected $2.020 billion and marking a 3.69% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:46 am

HUM

Humana shares rose following the company's announcement of better-than-expected Q3 adjusted EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:45 am

CPF

Central Pacific Financial (NYSE:CPF) reported Q3 earnings of $0.58 per share, beating estimates of $0.56 and showing an 18.37% increase from last year. Sales were $53.85M, surpassing the $53.25M estimate and marking a 3.70% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:42 am

NI

NiSource reaffirms its FY24 adjusted EPS guidance of $1.70-$1.74 and projects FY25 adjusted EPS in the range of $1.84-$1.88. The company plans a 6-8% annual EPS growth through 2029, driven by $19.3 billion in capital expenditures and 8-10% rate base growth.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:38 am

OMCL

Omnicell has announced its expectations for the fourth quarter of 2024, projecting total revenues between $295 million and $305 million, surpassing the estimated $287.89 million. The company also anticipates adjusted EPS between $0.55 and $0.62, exceeding the estimated $0.47.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:38 am

CMCO

Columbus McKinnon has issued its fiscal year 2025 guidance, projecting flat to low-single digit revenue growth and mid-single digit adjusted EPS growth. The company plans capital expenditures of $20-25 million and expects a net leverage ratio of approximately 2.3x.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:38 am

CMCO

Columbus McKinnon has issued guidance for Q3 FY25, expecting flat year-over-year growth in both net sales and adjusted EPS. The company anticipates $8 million in interest expense, $8 million in amortization, a 25% tax rate, and 28.9 million diluted shares outstanding.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:37 am

OMCL

Omnicell has updated its 2024 financial guidance, projecting revenues between $1.10B and $1.11B, slightly above the previous range. Adjusted EPS is expected to be between $1.65 and $1.72, higher than prior estimates. The company cites strong performance in the first three quarters of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:36 am